Argenx (ARGX)
(Delayed Data from NSDQ)
$371.02 USD
+8.86 (2.45%)
Updated May 31, 2024 04:00 PM ET
After-Market: $371.31 +0.29 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
argenex SE [ARGX]
Reports for Purchase
Showing records 101 - 120 ( 279 total )
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Q2 Preview Summertime and Sales Are Good Looking?
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
CHMP Recommendation No Surprise as Global Launch Remains On Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Vyvgart Remains in the Driver''s Seat in gMG
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
The Wedbush Monthly Check-Up: April 2022
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Positive Initial Feedback From Vyvgart Launch With Lots to Look Forward to in 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Vyvgart in the Avant Garde Commercially; Massive Push on Development Front
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Vyvgart in the Starting Blocks; Neurologist Survey
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Company: argenex SE
Industry: Medical - Biomedical and Genetics
Rx for Portfolios, Part 3: Commercial Launches Worth Keeping an Eye On
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D